Page 1 of Clinical Trials for Oral dose, 11190 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
TMC435350-TiDP16-C106: A Phase I Trial to Compare the Bioavailability and Plasma Pharmacokinetics After a Single Oral Dose of TMC435350 of 2 Different Solid Formulations Relative to a Powder Blend Capsule
Last Updated: April 26, 2010
Condition(s): Hepatitis C; HCV
2
Completed
PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir
Last Updated: April 26, 2010
Condition(s): HIV-1
3
Completed
TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients
Last Updated: December 15, 2011
Condition(s): Hepatitis C
4
Completed
An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands
Last Updated: June 23, 2011
Condition(s): Depressive Disorder and Anxiety Disorders; Depressive Disorder
5
Terminated
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
Last Updated: May 12, 2011
Condition(s): Infections, Bacterial
6
Completed
FTIH to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of GSK1322888 in Healthy Caucasian and Japanese Volunteers
Last Updated: February 16, 2012
Condition(s): Gastroparesis
7
Completed
A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects
Last Updated: February 16, 2012
Condition(s): Infections, Bacterial
8
Completed
A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
Last Updated: February 15, 2012
Condition(s): Healthy Subjects
9
Completed
Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects
Last Updated: March 18, 2010
Condition(s): Healthy
10
Completed
A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects
Last Updated: November 3, 2011
Condition(s): Healthy
11
Completed
Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers
Last Updated: July 13, 2010
Condition(s): Healthy
12
Completed
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
Last Updated: March 27, 2012
Condition(s): Healthy Volunteer
13
Completed
LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects
Last Updated: May 7, 2010
Condition(s): Psoriasis Vulgaris
14
Completed
First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187
Last Updated: January 14, 2010
Condition(s): Healthy
15
Completed
A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects
Last Updated: April 18, 2011
Condition(s): Healthy
16
Completed
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
Last Updated: June 6, 2011
Condition(s): Schizophrenia
17
Completed
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
Last Updated: May 3, 2011
Condition(s): Respiratory Tract Infections
18
Completed
Phase I, Exploratory, Single Centre, Single Oral Dose AZD9668 and Intravenous Microdose of [C14] AZD9668, Healthy Subject
Last Updated: February 8, 2011
Condition(s): Healthy
19
Completed
MD Ezetimibe Cyclosporine Interaction
Last Updated: April 13, 2009
Condition(s): Cholesterol
20
Completed
A Study to Evaluate the Pharmacokinetics and Absolute Bioavailability of GSK962040 Given as an Oral Dose Simultaneously With an Intravenous Microtracer Dose of [14C]-GSK962040 in Healthy Volunteers
Last Updated: July 26, 2011
Condition(s): Gastroparesis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Oral+dose

Page 1 of Clinical Trials for Oral dose, 11190 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About